# A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age

> **NCT06634797** · PHASE4 · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 1000 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** mRNA-1273.712
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06634797
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-01-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06634797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06634797, "A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT06634797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*